Bronte Capital Management Pty Ltd.
Source: SEC Form 13F · as of Mar 2026Bronte Capital Management Pty Ltd. holds 15 biotech & pharma companies tracked by BioSniper, totaling $298.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$298.1M
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 241,387 | $186.5M |
| PMPhilip Morris International Inc | 341,098 | $56.4M |
| NKTRNEKTAR THERAPEUTICS | 400,756 | $28.8M |
| HLFHerbalife Ltd. | 939,926 | $13.8M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 37,245 | $12.3M |
| ALECAlector, Inc. | 19,282 | $41K |
| CHRSCoherus Oncology, Inc. | 19,282 | $33K |
| CRBUCaribou Biosciences, Inc. | 15,627 | $30K |
| FATEFATE THERAPEUTICS INC | 22,853 | $27K |
| CCCCC4 Therapeutics, Inc. | 10,033 | $26K |
| PLRXPLIANT THERAPEUTICS, INC. | 18,613 | $23K |
| IVVDInvivyd, Inc. | 11,012 | $14K |
| MISTMilestone Pharmaceuticals Inc. | 10,414 | $12K |
| RANIRani Therapeutics Holdings, Inc. | 14,868 | $11K |
| GUTSFractyl Health Inc. | 16,905 | $8K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.